DrugDashboards

Butalbital, Aspirin, and Caffeine

Butalbital, Aspirin, and Caffeine · BUTALBITAL 50 mg/1; ASPIRIN 500 mg/1; CAFFEINE 40 mg/1 · Capsule · Oral · Lgm Pharma Solutions, Llc

NDC 79739-7192-01 · 100 CAPSULE in 1 BOTTLE · ANDA · View full market →

The short version

5 companies supply this market — a reasonable cushion if one runs into trouble.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.2%chance of a new FDA shortage posting for butalbital, aspirin, and caffeine (oral solid) in the next 90 days

OAI inspection at a producing facility (24 months) · sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program · Opioid Analgesic REMS Shared System REMS

Regulatory

Application
ANDA205230
TE code
—
Approval date
Oct 18, 2021
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Butalbital, Aspirin, and Caffeine (Capsule)

LabelerStrengthFirst seenLast seen
Chartwell RX, LLCBUTALBITAL 50 mg/1; ASPIRIN 325 mg/1; CAFFEINE 40 mg/1Aug 26, 2026Sep 2, 2026
Lannett Company, Inc.BUTALBITAL 50 mg/1; ASPIRIN 325 mg/1; CAFFEINE 40 mg/1Aug 26, 2026Sep 2, 2026
Lgm Pharma Solutions, LlcBUTALBITAL 50 mg/1; ASPIRIN 500 mg/1; CAFFEINE 40 mg/1Aug 26, 2026Sep 2, 2026
Sandoz IncBUTALBITAL 50 mg/1; ASPIRIN 325 mg/1; CAFFEINE 40 mg/1Aug 26, 2026Sep 2, 2026
Westminster Pharmaceuticals, LLCBUTALBITAL 50 mg/1; ASPIRIN 325 mg/1; CAFFEINE 40 mg/1Aug 26, 2026Sep 2, 2026
Chartwell RX, LLCBUTALBITAL 325 mg/1; ASPIRIN 50 mg/1; CAFFEINE 40 mg/1Jul 22, 2026Aug 19, 2026
Lannett Company, Inc.BUTALBITAL 325 mg/1; ASPIRIN 50 mg/1; CAFFEINE 40 mg/1Jul 22, 2026Aug 19, 2026
Lgm Pharma Solutions, LlcBUTALBITAL 500 mg/1; ASPIRIN 50 mg/1; CAFFEINE 40 mg/1Jul 22, 2026Aug 19, 2026
Sandoz IncBUTALBITAL 325 mg/1; ASPIRIN 50 mg/1; CAFFEINE 40 mg/1Jul 22, 2026Aug 19, 2026
Westminster Pharmaceuticals, LLCBUTALBITAL 325 mg/1; ASPIRIN 50 mg/1; CAFFEINE 40 mg/1Jul 22, 2026Aug 19, 2026
Chartwell RX, LLCASPIRIN 325 mg/1; BUTALBITAL 50 mg/1; CAFFEINE 40 mg/1Jul 15, 2026Jul 15, 2026
Lannett Company, Inc.ASPIRIN 325 mg/1; BUTALBITAL 50 mg/1; CAFFEINE 40 mg/1Jul 15, 2026Jul 15, 2026
Lgm Pharma Solutions, LlcASPIRIN 500 mg/1; BUTALBITAL 50 mg/1; CAFFEINE 40 mg/1Jul 15, 2026Jul 15, 2026
Sandoz IncASPIRIN 325 mg/1; BUTALBITAL 50 mg/1; CAFFEINE 40 mg/1Jul 15, 2026Jul 15, 2026
Westminster Pharmaceuticals, LLCASPIRIN 325 mg/1; BUTALBITAL 50 mg/1; CAFFEINE 40 mg/1Jul 15, 2026Jul 15, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Butalbital, Aspirin, and Caffeine — NDC 79739-7192-01," retrieved September 3, 2026, https://drugdashboards.com/drug/79739719201.

Free to cite with attribution — see how the data is put together.